Patients with and without history of atrial fibrillation after percutaneous coronary intervention increased focus on modifiable risk factors

被引：0
|
作者：
Kjoelseth, A. [1 ]
Norekvaal, T. M. [1 ]
Broers, G. [2 ]
Hendriks, J. M. [3 ]
Risom, S. S. [4 ]
Rotevatn, S. [1 ]
Wentzel-Larsen, T. [1 ]
Pettersen, T. R. [1 ]
机构：
[1] Haukeland Hosp, Dept Heart Dis, Bergen, Norway
[2] Trondheim Reg & Univ Hosp, St Olavs Hosp, Clin Cardiol, Trondheim, Norway
[3] Flinders Univ S Australia, Caring Futures Inst, Coll Nursing & Hlth Sci, Adelaide, Australia
[4] Herlev Gentofte Univ Hosp, Gentofte, Denmark
来源：
EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING | 2024年 / 23卷
关键词：
D O I：
10.1093/eurjcn/zvae098.095
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I123 / I123
页数：1
相关论文
共 50 条
  • [21] Clinical utility of the BIWACO score for patients with atrial fibrillation after percutaneous coronary intervention
    Takeda, Teruki
    Dohke, Tomohiro
    Ueno, Yoshiki
    Mastui, Toshiki
    Fujii, Masanori
    Takayama, Tomoyuki
    Dochi, Kenichi
    Miyamoto, Akashi
    Mabuchi, Hiroshi
    Wada, Atsuyuki
    HEART AND VESSELS, 2023, 38 (01) : 96 - 105
  • [22] Anticoagulant and Antiplatelet Prescribing Patterns for Patients with Atrial Fibrillation after Percutaneous Coronary Intervention
    Woods, Erin A.
    Ackman, Margaret L.
    Graham, Michelle M.
    Koshman, Sheri L.
    Boswell, Rosaleen M.
    Barry, Arden R.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2016, 69 (04): : 280 - 285
  • [23] Prognosis and antithrombotic therapy of patients with atrial fibrillation after undergoing percutaneous coronary intervention)
    Tanabe, Y.
    Tejima, T.
    Kitamura, T.
    Hojo, R.
    Komiyama, K.
    Fukamizu, S.
    Sakurada, H.
    Kobayashi, Y.
    EUROPEAN HEART JOURNAL, 2013, 34 : 353 - 354
  • [24] Clinical utility of the BIWACO score for patients with atrial fibrillation after percutaneous coronary intervention
    Teruki Takeda
    Tomohiro Dohke
    Yoshiki Ueno
    Toshiki Mastui
    Masanori Fujii
    Tomoyuki Takayama
    Kenichi Dochi
    Akashi Miyamoto
    Hiroshi Mabuchi
    Atsuyuki Wada
    Heart and Vessels, 2023, 38 : 96 - 105
  • [25] Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention
    Harskamp, Ralf E.
    Fanaroff, Alexander C.
    Lopes, Renato D.
    Wojdyla, Daniel M.
    Goodman, Shaun G.
    Thomas, Laine E.
    Aronson, Ronald
    Windecker, Stephan
    Mehran, Roxana
    Granger, Christopher B.
    Alexander, John H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (05) : 417 - 427
  • [26] Antithrombotic therapy in patients with atrial fibrillation after myocardial infarction and percutaneous coronary intervention
    Skibniewski, M.
    Venetsanos, D.
    Zwackman, S.
    Batra, G.
    Janzon, M.
    Karlsson, L. O.
    Alfredsson, J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [27] Prevalence and Impact of Standard Modifiable Risk Factors Among Patients Undergoing Percutaneous Coronary Intervention
    Nicolas, Johny
    Oliva, Angelo
    Sartori, Samantha
    Vogel, Birgit
    Gitto, Mauro
    Di Muro, Francesca Maria
    Bay, Benjamin
    Granada, Laura
    Kim, Chan Joon
    Gujjarllamudi, Sai Vijaya Lakshmi
    Sharma, Raman
    Sweeny, Joseph
    Hooda, Amit
    Serrao, Gregory
    Kini, Annapoorna
    Dangas, George
    Sharma, Samin
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B46 - B46
  • [28] CORRELATIONS OF VISFATIN WITH SEVERITY OF ACUTE MYOCARDIAL INFARCTION, CARDIOVASCULAR RISK FACTORS AND ATRIAL FIBRILLATION AFTER PERCUTANEOUS CORONARY INTERVENTION
    Zhang, Huihui
    Lei, Dingwei
    Zhang, Miaolin
    Tu, Sijia
    Shen, Chaofeng
    Lin, Fengxian
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2023, 42 (04) : 650 - 657
  • [29] Epidemiology and modifiable risk factors for atrial fibrillation
    Adrian D. Elliott
    Melissa E. Middeldorp
    Isabelle C. Van Gelder
    Christine M. Albert
    Prashanthan Sanders
    Nature Reviews Cardiology, 2023, 20 : 404 - 417
  • [30] Stent Thrombosis With and Without Aspirin After Percutaneous Coronary Intervention in Patients With or Without Atrial Fibrillation: Do We Still Need Aspirin?
    IJff, Georges C.
    Herrman, Jean Paul R.
    Verheugt, Freek W.
    CIRCULATION, 2017, 136
12345